Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $114.1500 (0.1%) ($113.3500 - $115.7000) on Fri. Jun. 28, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.09% (three month average) | RSI | 54 | Latest Price | $114.1500(0.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.4% a day on average for past five trading days. | Weekly Trend | LGND advances 0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.045% in a week (0% probabilities). VIXM(-33%) VXX(-21%) TLT(-15%) IFRA(-8%) UUP(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.045% (StdDev 2.09%) | Hourly BBV | 0 () | Intraday Trend | -0.1% | | | |
|
5 Day Moving Average | $111.78(2.12%) | 10 Day Moving Average | $112.3(1.65%) | 20 Day Moving Average | $111.98(1.94%) | To recent high | -11.7% | To recent low | 6.3% | Market Cap | $1.835b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |